Lisinopril 1 mg/ml Oral Solution
Authorisation PA23081/013/001 · Taw Pharma (Ireland) Limited
- Licence holder
- Taw Pharma (Ireland) Limited (all products →)
- Active substance
- Lisinopril Dihydrate
- Dosage form
- Oral solution
- Route of administration
- Oral use
- ATC codes
- C09AA, C09AA03
- First authorised
- 31/07/2015
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Lisinopril Dihydrate: supply and approvals
20 authorised products on the HPRA list contain Lisinopril Dihydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 11 years (since 31 July 2015). The HPRA list marks it as not marketed: it is licensed but the holder has not reported it as on sale.
Other medicines with Lisinopril Dihydrate in Ireland
14 other products on the HPRA list contain Lisinopril Dihydrate, from 5 licence holders; 11 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Lisopress 10 mg tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Lisopress 20 mg tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Lisopress 5 mg tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Lispril 5 mg Tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Lispril-Hydrochlorothiazide 10 mg/12.5 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Lispril-Hydrochlorothiazide 20 mg/12.5 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Zestan 10 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Zestan 2.5mg Tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Zestan 20 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Zestan 5mg Tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Zestoretic 10 mg /12.5 mg Tablets | Atnahs Pharma Netherlands B.V. | National authorisation (PA) | Marketed |
| Lisinopril Grindeks 10 mg tablets | AS Grindeks | National authorisation (PA) | Not marketed |
Other substances in ATC group C09AA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 9 other active substances share the group C09AA with this product:
Ramipril (19) · Enalapril maleate (10) · Perindopril tert-butylamine (6) · Lisinopril (4) · Perindopril arginine (3) · Lisinopril (as dihydrate) (2) · Trandolapril (2) · Perindopril tosilate (2) · Zofenopril calcium (2)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Taw Pharma (Ireland) Limited holds 11 products on the HPRA list, with 14 different active substances; 6 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.